You're reading the free version. Trader adds the live tape and alerts.
Start tracking
AARD Disposition Disclosure
Lee Tien-li · SEC Form 4 · Filed Nov 10, 2026
Disposition
Reported value range
Not reported
Lee Tien-li Chief Executive Officer
AARD
Transaction date
Nov 6, 2026
Public filing date
Nov 10, 2026
Filing lag
Filed 4 days later
AARD daily price context
Close on/before transaction
$1.17
Nov 6, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Stock Option (right to buy) on Common Stock
- Quantity / price
- 203,851 shares
- SEC ownership
- Direct
- Transaction code
- D
- Form
- 4
- Filing identifier
- 0001193125-26-455757
Filing cohort
Transactions in this filing
Showing 6 of 6
Trades
6
Issuers
1
Estimated value
Not reported
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aardvark Therapeutics, Inc. AARD | Disposition | Nov 6, 2026 | Not reported |
| Aardvark Therapeutics, Inc. AARD | Award | Nov 6, 2026 | Not reported |
| Aardvark Therapeutics, Inc. AARD | Award | Nov 6, 2026 | Not reported |
| Aardvark Therapeutics, Inc. AARD | Disposition | Nov 6, 2026 | Not reported |
| Aardvark Therapeutics, Inc. AARD Current | Disposition | Nov 6, 2026 | Not reported |
| Aardvark Therapeutics, Inc. AARD | Award | Nov 6, 2026 | Not reported |